[{"address1": "535 W 24th Street", "address2": "5th Floor", "city": "New York", "state": "NY", "zip": "10011", "country": "United States", "phone": "855 508 3568", "website": "https://www.neurogene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rachel L. McMinn Ph.D.", "age": 51, "title": "Founder, Executive Chair & CEO", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 929410, "exercisedValue": 0, "unexercisedValue": 249075}, {"maxAge": 1, "name": "Ms. Christine Mikail Cvijic J.D.", "age": 46, "title": "President & CFO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 746750, "exercisedValue": 0, "unexercisedValue": 1035052}, {"maxAge": 1, "name": "Dr. Julie  Jordan M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 651036, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Arvind  Sreedharan", "title": "Senior Vice President of Business Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stuart  Cobb Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 478807, "exercisedValue": 0, "unexercisedValue": 338906}, {"maxAge": 1, "name": "Ms. Donna M. Cochener-Metcalfe J.D.", "age": 49, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Effie  Albanis M.D.", "title": "Senior Vice President of Early Clinical & Translational Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew E. Mulberg CPI, FAAP, M.D.", "title": "Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ricardo  Jimenez", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 33.14, "open": 34.46, "dayLow": 32.83, "dayHigh": 35.47, "regularMarketPreviousClose": 33.14, "regularMarketOpen": 34.46, "regularMarketDayLow": 32.83, "regularMarketDayHigh": 35.47, "payoutRatio": 0.0, "forwardPE": -7.3836207, "volume": 214772, "regularMarketVolume": 214772, "averageVolume": 180060, "averageVolume10days": 213740, "averageDailyVolume10Day": 213740, "bid": 33.84, "ask": 34.78, "bidSize": 1, "askSize": 1, "marketCap": 488955808, "fiftyTwoWeekLow": 6.875, "fiftyTwoWeekHigh": 74.49, "allTimeHigh": 1115.0, "allTimeLow": 6.875, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 23.5233, "twoHundredDayAverage": 18.93465, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 225402848, "profitMargins": 0.0, "floatShares": 4799645, "sharesOutstanding": 14271916, "sharesShort": 2858834, "sharesShortPriorMonth": 2823152, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.20030001, "heldPercentInsiders": 0.09273, "heldPercentInstitutions": 1.10157, "shortRatio": 13.0, "shortPercentOfFloat": 0.2542, "impliedSharesOutstanding": 14271916, "bookValue": 19.15, "priceToBook": 1.7890339, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -84394000, "trailingEps": -4.31, "forwardEps": -4.64, "lastSplitFactor": "1:4", "lastSplitDate": 1702944000, "enterpriseToEbitda": -2.435, "52WeekChange": -0.4809091, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 34.26, "targetHighPrice": 70.0, "targetLowPrice": 45.0, "targetMeanPrice": 52.75, "targetMedianPrice": 48.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 274519008, "totalCashPerShare": 19.235, "ebitda": -92558000, "totalDebt": 10966000, "quickRatio": 17.865, "currentRatio": 18.069, "totalRevenue": 0, "debtToEquity": 4.013, "revenuePerShare": 0.0, "returnOnAssets": -0.25069, "returnOnEquity": -0.39411998, "grossProfits": -68763000, "freeCashflow": -42645500, "operatingCashflow": -73296000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NGNE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_602062523", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.3796, "regularMarketPrice": 34.26, "shortName": "Neurogene Inc.", "longName": "Neurogene Inc.", "earningsTimestampStart": 1763150400, "earningsTimestampEnd": 1763150400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.31, "epsForward": -4.64, "epsCurrentYear": -4.32, "priceEpsCurrentYear": -7.930555, "fiftyDayAverageChange": 10.736698, "fiftyDayAverageChangePercent": 0.45642823, "twoHundredDayAverageChange": 15.325348, "twoHundredDayAverageChangePercent": 0.80938107, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1761942679, "regularMarketTime": 1761940801, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394202600000, "postMarketChangePercent": 0.0, "postMarketPrice": 34.26, "postMarketChange": 0.0, "regularMarketChange": 1.12, "regularMarketDayRange": "32.83 - 35.47", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 180060, "fiftyTwoWeekLowChange": 27.384998, "fiftyTwoWeekLowChangePercent": 3.9832726, "fiftyTwoWeekRange": "6.875 - 74.49", "fiftyTwoWeekHighChange": -40.23, "fiftyTwoWeekHighChangePercent": -0.5400725, "fiftyTwoWeekChangePercent": -48.09091, "marketState": "CLOSED", "displayName": "Neurogene", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]